Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
NCT ID: NCT01632956
Last Updated: 2014-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2012-06-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Breast Cancer Screening in Chinese Immigrants
NCT05089292
Breast Health in Chinese American Women
NCT01292200
Experience of Arab American Women With Breast Cancer: In-depth Interviews
NCT02710058
Chinese Women and Mammography Screening
NCT01261520
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
NCT00145197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
in-person support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
in-person support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
virtual support group
This is a 1 year pilot study of the feasibility of participation in both in-person and virtual information-based, culturally tailored support groups for Chinese breast cancer patients.
virtual support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
in-person support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
virtual support group
Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-US born
* Resident in the US \< 20 years
* Of Chinese descent
* Age 21 years through 80 years
* Language spoken: Mandarin
* Diagnosis of breast cancer within 3 months prior to recruitment
\*Not required that breast cancer is the patients' first and/or only cancer diagnosis
* Currently receiving cancer treatment;
* Will be living continuously in the US for the next year
* Has a telephone that he/she is willing to use for the study
Exclusion Criteria
* Another household member is already enrolled.
* Prior participation in a cancer support group
21 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Support Community
UNKNOWN
CHARLES B WANG COMMUNITY HEALTH CENTER
UNKNOWN
Queens Health Network
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Leng, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queens Cancer Center of Queens Hospital
Jamaica, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan-Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.